Table 1.
The timeline of clinical indicators levels relative to treatment
| Time | Scr (mmol/L) | 24 h UTP (g/24 h) | C3 (g/L) | Serum-free lambda light chain (g/L) | Urine lambda light chain (g/L) |
|---|---|---|---|---|---|
| 2017.11.15 BD | 0.0606 | 0.13 | 0.047 | 8.05 | 0.517 |
| 2017.12.26 BD | 0.0541 | 0.09 | 0.058 | 5.05 | 0.005 |
| 2018.01.22 BD | 0.0563 | 0.14 | 0.632 | 3.11 | 0.005 |
| 2018.02.20 BD | 0.0581 | 0.16 | 0.661 | 1.55 | 0.005 |
| 2018.04.10 CTX* | 0.0605 | 0.15 | 0.258 | 3.67 | 0.005 |
| 2018.06.19 PAD | 0.0668 | 0.16 | 0.189 | 3.71 | 0.005 |
| 2018.09.04 after autoHCT | 0.0572 | 0.14 | 0.175 | 3.89 | 0.005 |
Abbreviations: Scr serum creatinine, 24 h UTP 24-h urinary protein quantity, BD bortezomib plus dexamethasone, CTX* mobilisation with cyclophosphamide, PAD bortezomib plus doxorubicin and dexamethasone, autoHCT autologous stem cell transplantation